Clinical Trial Update: Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases [Phase 1]

View source ↗

Summary

Phase 1 safety study of oxaliplatin and 5-fluorouracil followed by floxuridine for unresectable colorectal cancer with liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Floxuridine (FUDR) (floxuridine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: David Bartlett | Conditions: Colorectal Liver Metastases | Phase 1 | Status: COMPLETED